Marketing-authorisation holder · Spain
Alfasigma Espana S.L.
33 medicines in 1 country, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
33 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 33
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEDIUR 20 mg/12.5mg comprimidos12,5 mg + 20 mg · Comprimido | Hydrochlorothiazide, Enalapril | Spain | Marketed | 1993 |
| ALACAPSIN 0.075 % CREMA0,075 g · Crema | Capsaicin | Spain | Marketed | 2007 |
| ANGILEPTOL COMPRIMIDOS PARA CHUPAR SABOR MENTA3 mg + 4 mg + 5 mg · Comprimido para chupar | Enoxolona, Benzocaine, Clorhexidina dihidrocloruro | Spain | Marketed | 1969 |
| ANGILEPTOL COMPRIMIDOS PARA CHUPAR SABOR MENTA-EUCALIPTO5,00 mg + 4,00 mg + 3,00 mg · Comprimido para chupar | Clorhexidina dihidrocloruro, Benzocaine, Enoxolona | Spain | Marketed | 2007 |
| ANGILEPTOL COMPRIMIDOS PARA CHUPAR SABOR MIEL-LIMÓN3 mg + 4 mg + 5 mg · Comprimido para chupar | Enoxolona, Benzocaine, Clorhexidina dihidrocloruro | Spain | Marketed | 2001 |
| ANGITUSS 6MG/ML JARABE60 mg · Jarabe | Levodropropizina | Spain | Marketed | 1997 |
| ATERINA 15 mg CAPSULAS BLANDAS150 ul · Cápsula blanda | Sulodexida | Spain | Marketed | 1982 |
| ATERINA 25 MG CÁPSULAS BLANDAS25 mg · Cápsula blanda | Sulodexida | Spain | Marketed | 2025 |
| ATERINA 60 MG/2 ML SOLUCION INYECTABLE60 mg · Solución inyectable | Sulodexida | Spain | Marketed | 2018 |
| CARNICOR 100 mg/ml SOLUCION ORAL1 g · Solución oral | L-carnitine | Spain | Marketed | 1980 |
| CARNICOR 200 mg/ ml SOLUCION INYECTABLE1000 mg · Solución inyectable | L-carnitine | Spain | Marketed | 1980 |
| CARNICOR 300 mg/ml SOLUCION ORAL1,5 g · Solución oral | L-carnitine | Spain | Marketed | 1979 |
| CARRELDON RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA240 mg · Comprimido de liberación modificada | Diltiazem | Spain | Marketed | 1995 |
| CLENSIA POLVO PARA SOLUCION ORAL52,500 g + 3,750 g + 0,080 g + 1,863 g + 0,813 g + 0,730 g + 0,370 g · Polvo para solución oral | Macrogol, Sodio sulfato anhidro, Dimethicone, Citrato sodio, Citric acid, Cloreto, Potassium | Spain | Marketed | 2017 |
| DILTIWAS RETARD 120 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA120 mg · Cápsula dura de liberación prolongada | Diltiazem | Spain | Marketed | 1993 |
| DOLAK RETARD 60 mg COMPRIMIDOS DE LIBERACION PROLONGADA60 mg · Comprimido de liberación prolongada | Isosorbide mononitrate | Spain | Marketed | 1992 |
| GASTROFRENAL 100 mg, CAPSULAS DURAS100 mg · Cápsula dura | Cromoglicic acid | Spain | Marketed | 1993 |
| GASTROFRENAL 200 mg, CAPSULAS DURAS200 mg · Cápsula dura | Cromoglicic acid | Spain | Marketed | 1995 |
| LINITUL ANTISEPTICO 10 MG/ML SOLUCION PARA PULVERIZACION CUTANEA10 mg/ml · Solución para pulverización cutánea | Chlorhexidine | Spain | Marketed | 2023 |
| LINITUL CICATRIZANTE APOSITO IMPREGNADO0,185 mg + 1,678 mg · Apósito impregnado | Peru balsam, Aceite ricino | Spain | Marketed | 1959 |
| LINITUL CICATRIZANTE POMADA2 g + 15 g · Pomada | Peru balsam, Aceite ricino | Spain | Marketed | 1959 |
| MAYESTA 10 mg CAPSULAS BLANDAS10 mg · Cápsula blanda | Isotretinoin | Spain | Marketed | 2008 |
| MAYESTA 20 mg CAPSULAS BLANDAS20 mg · Cápsula blanda | Isotretinoin | Spain | Marketed | 2008 |
| NAPRILENE 20 mg COMPRIMIDOS20 mg · Comprimido | Enalapril | Spain | Marketed | 1988 |
| PERIACTIN 4 MG COMPRIMIDOS4 mg · Comprimido | Cyproheptadine | Spain | Marketed | 1961 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 33 | 27 | 6 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.